|
Mar 19
|
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
|
|
Mar 15
|
Insider Sell: President and CEO William Greenman Sells 125,926 Shares of Cerus Corp (CERS)
|
|
Mar 15
|
Insider Sell: COO Vivek Jayaraman Sells 53,041 Shares of Cerus Corp (CERS)
|
|
Mar 8
|
Earnings Release: Here's Why Analysts Cut Their Cerus Corporation (NASDAQ:CERS) Price Target To US$4.13
|
|
Mar 7
|
Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven
|
|
Mar 7
|
Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Cerus Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Mar 6
|
Q4 2023 Cerus Corp Earnings Call
|
|
Mar 5
|
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
|
|
Feb 23
|
12 Best Rising Penny Stocks To Buy
|
|
Feb 20
|
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
|
|
Jan 15
|
3 Growth Stocks That Could Go Parabolic in 2024
|